[Syn+ec+tics]:- an approach to solving problems based on the creative thinking of a group of people from different areas of expertise and knowledge......
The increasing number of poorly soluble compounds entering development is causing companies to invest more time and resource into evaluating and enhancing drug solubility and dissolution velocity. However, do you have enough up-to-the-minute information on what approaches are proving successful – and when? Which technologies should you be applying to enhance the solubility and bioavailability of your drug candidates and at what stage of development are these technologies applicable?
At Synectix Pharmaceutical Solutions Ltd, we develop new generation pharmaceutical and biopharmaceutical products using our proprietary drug formulation technologies which are applied to enhance the delivery of poorly soluble new chemical entities (NCEs) and commercial compounds showing poor bioavailability, as well as rescuing potential R&D drop-outs.
Our core research efforts are focused on the application of bespoke particle processing and drug activation technologies to produce soluble intermediates for liquid, solid and semi-solid dosage forms. Using these technologies, we turn difficult drug candidates into easy to administer, stable, and successful pharmaceutical products.
Our core services include:
To see how you may benefit from having us as an extension of your own R&D capabilities, please click on the appropriate link above or contact us today for an informal and confidential discussion.
